Prof Dr Nathalie Meuleman, haematologist at the Institut Jules Bordet in...
Dr Fredrik Schjesvold, director of the Oslo Myeloma Center at the Oslo...
Prof Timothy Devos, a haematologist at UZ Leuven, chaired a session on...
Prof Claudio Cerchione, haematologist at the Istituto Scientifico Romagnolo per...
Prof Claudio Cerchione, a haematologist at the Istituto Scientifico Romagnolo...
Dr Evren Alici, principal researcher and head of the cell and gene therapy...
In this presentation, data sourced from the CIBM-TR registry were utilized to...
At the ASH meeting, Professor Oliva presented the patient-reported outcomes...
Prof Claudio Cerchione, haematologist at the Istituto Scientifico Romagnolo per...
KarMMa-3 constitutes an open-label, phase 3 randomized clinical trial aimed at...